Hugo Cuellar1, Leopoldo Guimaraens2, Sudheer Ambekar3, Elio Vivas4, Jacques Theron5. 1. Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, LA, USA hcuell@lsuhsc.edu. 2. Department of Interventional Neuroradiology, Hospital General de Catalunya, Neuroangiografia Terapeutica, Barcelona, Spain Department of Interventional Neuroradiology, Hospital Nuestra Señora del Rosario, Terapeutica Endovascular y Percutanea, Madrid, Spain. 3. Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, LA, USA. 4. Department of Interventional Neuroradiology, Hospital General de Catalunya, Neuroangiografia Terapeutica, Barcelona, Spain. 5. Department of Interventional Neuroradiology, Hospital Nuestra Señora del Rosario, Terapeutica Endovascular y Percutanea, Madrid, Spain.
Abstract
INTRODUCTION: Direct carotid artery puncture (DCP) is employed in patients with tortuous anatomy and peripheral vascular disease when the peripheral arteries are not available for vascular access. Manual compression is the only method of achieving hemostasis following DCP and, till date, the use of a closure device for DCP has been reported in only one patient. In this study we sought to analyze our experience with the use of closure device for DCP. METHODS: This is a retrospective study of patients in whom Angioseal™ was used following DCP for neuroendovascular procedures. Medical charts and imaging of these patients was reviewed for any abnormalities pertaining to the use of the closure device. RESULTS: A total of eight patients were included in the study. Angioseal™ was used in all the patients. There were no complications related to the use of the closure device in any of the eight patients. Immediate post-procedure angiography done in one patient did not show any structural or hemodynamic abnormalities within the carotid artery lumen. At 6 months follow-up imaging, there was no evidence stenosis or vascular wall abnormality in any of the patients. There were no adverse clinical reactions related to the use of closure device. CONCLUSION: In our experience, Angioseal™ may be a safe and off-label effective closure device for patients undergoing DCP for neuroendovascular procedures. It obviates the need for manual compression without causing any structural or hemodynamic changes within the carotid artery. Larger studies with longer follow-up are required to establish its safety in patients undergoing DCP.
INTRODUCTION: Direct carotid artery puncture (DCP) is employed in patients with tortuous anatomy and peripheral vascular disease when the peripheral arteries are not available for vascular access. Manual compression is the only method of achieving hemostasis following DCP and, till date, the use of a closure device for DCP has been reported in only one patient. In this study we sought to analyze our experience with the use of closure device for DCP. METHODS: This is a retrospective study of patients in whom Angioseal™ was used following DCP for neuroendovascular procedures. Medical charts and imaging of these patients was reviewed for any abnormalities pertaining to the use of the closure device. RESULTS: A total of eight patients were included in the study. Angioseal™ was used in all the patients. There were no complications related to the use of the closure device in any of the eight patients. Immediate post-procedure angiography done in one patient did not show any structural or hemodynamic abnormalities within the carotid artery lumen. At 6 months follow-up imaging, there was no evidence stenosis or vascular wall abnormality in any of the patients. There were no adverse clinical reactions related to the use of closure device. CONCLUSION: In our experience, Angioseal™ may be a safe and off-label effective closure device for patients undergoing DCP for neuroendovascular procedures. It obviates the need for manual compression without causing any structural or hemodynamic changes within the carotid artery. Larger studies with longer follow-up are required to establish its safety in patients undergoing DCP.
Authors: Eugenia Nikolsky; Roxana Mehran; Amir Halkin; Eve D Aymong; Gary S Mintz; Zoran Lasic; Manuela Negoita; Martin Fahy; Shoshana Krieger; Issam Moussa; Jeffrey W Moses; Gregg W Stone; Martin B Leon; Stuart J Pocock; George Dangas Journal: J Am Coll Cardiol Date: 2004-09-15 Impact factor: 24.094
Authors: J D Fields; K C Liu; D S Lee; S J Gonda; A Dogan; S H Gultekin; G M Nesbit; B D Petersen; S L Barnwell Journal: AJNR Am J Neuroradiol Date: 2010-06-10 Impact factor: 3.825
Authors: Manesh R Patel; Hani Jneid; Colin P Derdeyn; Lloyd W Klein; Glenn N Levine; Robert A Lookstein; Christopher J White; Yerem Yeghiazarians; Kenneth Rosenfield Journal: Circulation Date: 2010-10-04 Impact factor: 29.690
Authors: Bernardo Massière; Arno von Ristow; José Mussa Cury; Marcus Gress; Alberto Vescovi; Cleoni Pedron; Antônio Luiz Medina; Marcos Areas Masques; Paulo Roberto Silveira; Salim Jeha Journal: Ann Vasc Surg Date: 2008-09-09 Impact factor: 1.466
Authors: K Nii; K Kazekawa; M Onizuka; H Aikawa; M Tsutsumi; M Tomokiyo; M Iko; T Kodama; S Matsubara; Y Go; A Tanaka Journal: AJNR Am J Neuroradiol Date: 2006-08 Impact factor: 3.825
Authors: Jong Young Lee; Jong-Hwa Park; Hong Jun Jeon; Dae Young Yoon; Seoung Woo Park; Byung Moon Cho Journal: Neuroradiology Date: 2018-03-01 Impact factor: 2.804
Authors: Giuseppe Guzzardi; Bruno Del Sette; Carmelo Stanca; Andrea Paladini; Andrea Galbiati; Marco Spinetta; Massimiliano Cernigliaro; Massimiliano Leigheb; Alessandro Carriero Journal: Brain Sci Date: 2020-05-25